Ypsomed Holding AG

Price Chart

Risk-Adjusted Performance

Also Listed On

Ypsomed Holding AG (YPSN) Price Performance

Ypsomed Holding AG (YPSN) trades on SIX Swiss Exchange in CHF. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at CHF297.40, up 2.06% from the previous close.

Over the past year, YPSN has traded between a low of CHF267.00 and a high of CHF436.00. The stock has lost 8.0% over this period. It is currently 31.8% below its 52-week high.

Ypsomed Holding AG has a market capitalization of $4.05B, with a price-to-earnings ratio of 20.87 and a dividend yield of 0.75%.

About Ypsomed Holding AG

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.